NEW ORAL PHARMACEUTICAL COMPOSITION AND DOSE REGIMEN FOR THE THERAPY OF PROGRESSIVE… Application WO-2023104958-A1 World Intellectual Property Organisation (WIPO) 15 Jun 2023
Novel combinations of active agents for the treatment of interstitial lung disease with… Grant JP-7196169-B2 Japan 26 Dec 2022
Antibodies that bind IL-4 and/or IL-13 and their uses Grant US-11453727-B2 United States of America 27 Sep 2022
Antibodies that bind IL-4 and/or IL-13 and their uses Grant US-10759871-B2 United States of America 01 Sep 2020